Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia.
CML
chronic myeloid leukemia
dPCR
digital PCR
digital polymerase chain reaction
minimal residual disease
Journal
Diseases (Basel, Switzerland)
ISSN: 2079-9721
Titre abrégé: Diseases
Pays: Switzerland
ID NLM: 101636232
Informations de publication
Date de publication:
05 May 2021
05 May 2021
Historique:
received:
12
11
2020
revised:
30
04
2021
accepted:
03
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
In recent years, the digital polymerase chain reaction has received increasing interest as it has emerged as a tool to provide more sensitive and accurate detection of minimal residual disease. In order to start the process of data alignment, we assessed the consistency of the BCR-ABL1 quantification results of the analysis of 16 RNA samples at different levels of disease. The results were obtained by two different laboratories that relied on The Qx100/Qx200 Droplet Digital PCR System (Bio-Rad) and Quant Studio 3D dPCR System (Thermofisher) platforms. We assessed the compatibility between the estimated values by linear regression, Bland-Altman bias-plot, and Mann-Whitney nonparametric test. The results confirmed the compatibility of the measures, allowing us tocompute an 'alignment factor' (AF), equal to 1.41, which was further validated by a different series of experiments. We conclude that the performed measurements by the two laboratories are comparable, and also equalized through the introduction of an alignment factor.
Identifiants
pubmed: 34062996
pii: diseases9020035
doi: 10.3390/diseases9020035
pmc: PMC8161814
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet. 2007 Jul 28;370(9584):342-50
pubmed: 17662883
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
Leukemia. 2016 Sep;30(9):1844-52
pubmed: 27109508
Case Rep Oncol. 2020 Oct 15;13(3):1263-1269
pubmed: 33250741
Blood. 2013 Aug 8;122(6):872-84
pubmed: 23803709
Am J Hematol. 2015 Oct;90(10):910-4
pubmed: 26178642
Leukemia. 2009 Nov;23(11):1957-63
pubmed: 19710700
Ann Hematol. 2015 Apr;94 Suppl 2:S187-93
pubmed: 25814085
J Natl Cancer Inst. 2011 Apr 6;103(7):553-61
pubmed: 21422402
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Blood. 2008 Oct 15;112(8):3330-8
pubmed: 18684859
Leukemia. 2009 Jun;23(6):1054-61
pubmed: 19282833
Leuk Lymphoma. 2011 May;52(5):896-904
pubmed: 21338281
Cancers (Basel). 2020 Nov 06;12(11):
pubmed: 33172063
Blood. 2010 Nov 25;116(22):e111-7
pubmed: 20720184
Biomol Detect Quantif. 2017 Feb 14;11:4-20
pubmed: 28331814
Anal Chem. 2012 Jan 17;84(2):1003-11
pubmed: 22122760
Eur J Haematol. 2019 Sep;103(3):272-273
pubmed: 31233644
Leukemia. 2015 May;29(5):999-1003
pubmed: 25652737
J Mol Diagn. 2014 Mar;16(2):174-9
pubmed: 24389534
Int J Mol Sci. 2019 May 07;20(9):
pubmed: 31067725
Cancer Med. 2019 May;8(5):2041-2055
pubmed: 30950237
Clin Chem. 2017 Feb;63(2):525-531
pubmed: 27979961
Clin Chem. 2015 Jan;61(1):79-88
pubmed: 25338683
Anal Bioanal Chem. 2009 May;394(2):457-67
pubmed: 19288230
J Clin Oncol. 2016 Aug 20;34(24):2851-7
pubmed: 27325849
Ann Hematol. 2015 Apr;94 Suppl 2:S141-7
pubmed: 25814080
Leukemia. 2015 Jun;29(6):1336-43
pubmed: 25783795
Blood. 2020 Nov 5;136(19):2237-2240
pubmed: 32518953
J Hematol Oncol. 2019 Jan 3;12(1):1
pubmed: 30606227
N Engl J Med. 2003 Oct 9;349(15):1423-32
pubmed: 14534335
J Clin Oncol. 2011 Apr 20;29(12):1634-42
pubmed: 21422420
Biosens Bioelectron. 2017 Apr 15;90:459-474
pubmed: 27818047
Lancet Oncol. 2018 Jun;19(6):747-757
pubmed: 29735299
Blood. 2012 Mar 1;119(9):1981-7
pubmed: 22228624